SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-19-179321
Filing Date
2019-06-24
Accepted
2019-06-24 07:12:20
Documents
16

Document Format Files

Seq Description Document Type Size
1 S-1/A d613995ds1a.htm S-1/A 80413
2 EX-1.1 d613995dex11.htm EX-1.1 204670
3 EX-3.2 d613995dex32.htm EX-3.2 25651
4 EX-3.4 d613995dex34.htm EX-3.4 103493
5 EX-4.1 d613995dex41.htm EX-4.1 5151
6 EX-4.3 d613995dex43.htm EX-4.3 96904
7 EX-10.1 d613995dex101.htm EX-10.1 260908
8 EX-10.2 d613995dex102.htm EX-10.2 40010
9 EX-10.3 d613995dex103.htm EX-10.3 14797
10 EX-10.4 d613995dex104.htm EX-10.4 69698
11 EX-10.5 d613995dex105.htm EX-10.5 66894
12 EX-10.27 d613995dex1027.htm EX-10.27 109452
13 EX-10.28 d613995dex1028.htm EX-10.28 69971
14 EX-21 d613995dex21.htm EX-21 11735
15 GRAPHIC g706243g15d41.jpg GRAPHIC 146968
16 GRAPHIC g706243g78m09.jpg GRAPHIC 397912
  Complete submission text file 0001193125-19-179321.txt   1911553
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-231759 | Film No.: 19913248
SIC: 2834 Pharmaceutical Preparations